Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
national blog main
national top stories
startups
texas blog main
texas top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
ancor capital partners
antibiotics
australia
axial spondyloarthritis
bausch health
biobridge
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
darlene boudreaux
deals
detroit blog main
detroit top stories
diagnostics
diana murakhovskaya
digital health
What
new
2
×
news
2
×
roundup
2
×
announced
approval
bio
biobridge
biogen’s
biopharmaceutical
catch
center
companies
convo
drug
earlier
execs
expansion
failures
fannin
innovation
latest
let’s
littered
medical
nash
price
program
remains
road
strategy
talk
techfw
texas
tmc’s
tx
uk
united
Language
Current search:
roundup
×
new
×
news
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW